-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Hold on Calumet, Lowers Price Target to $37

Benzinga·11/18/2026 14:46:00
Listen to the news
TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Hold and lowers the price target from $40 to $37.